Mukhopadhyay, Bani http://orcid.org/0000-0002-9854-9418
Marietta, Cheryl
Shen, Pei-Hong
Oiseni, Abdul
Mirshahi, Faridoddin
Mazzu, Maria
Hodgkinson, Colin
Winkler, Eli
Yuan, Qiaoping http://orcid.org/0000-0002-5880-8702
Miranda, Daniel http://orcid.org/0009-0001-1178-917X
Kunos, George
Sanyal, Arun J. http://orcid.org/0000-0001-8682-5748
Goldman, David http://orcid.org/0000-0002-1724-5405
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (ZIA AA000301, ZIA AA000421)
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism
Article History
Received: 28 May 2023
Accepted: 15 March 2024
First Online: 1 May 2024
Competing interests
: The authors do not have any financial and non-financial interest in design or preparation of the manuscript. D.M. receives a salary from Leica Microsystems where he is Manager for Aivia Software, however received no compensation to assist for this manuscript. A.J.S. have stock options in Genfit, Akarna, Tiziana, Durect Inversago, and Galmed. He has served as a consultant to Astra Zeneca, Salix, Tobira, Takeda, Jannsen, Gilead, Terns, Birdrock, Merck, Valeant, Boehringer Ingelheim, Bristol Myers Squibb, Lilly, Hemoshear, Novartis, Novo Nordisk, Pfizer, 89 bio, Regeneron, Alnylam, Akero, Tern, Histoindex, Corcept, Poxel, Path AI, and Genfit. His institution has received grant support from Gilead, Salix, Tobira, Bristol Myers, Shire, Intercept, Merck, Astra Zeneca, Malinckrodt and Novartis. He receives royalties from Elsevier and UptoDate. However, A.J.S. received no compensation from any source for this manuscript.